NEW YORK, Jan 3 (Reuters) - Johnson & Johnson’s (JNJ.N: Quote, Profile, Research) Scios Inc. unit on Tuesday said it had informed U.S. regulators of two previously unreported deaths among patients taking its Natrecor heart failure drug in a prior study of the medicine.